---
title: Delpharm vs UPM Pharmaceuticals
slug_a: delpharm
slug_b: upm-inc
site: cdmo
review_signal_gate: closed
canonical_path: /compare/delpharm/upm-inc
generated_by: BioBM Editorial AI
---

# Delpharm vs UPM Pharmaceuticals

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Delpharm (delpharm) is listed for cdmo. Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.

Services: 14. Modalities: 2. Indications: 0. Locations: 36. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (36).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

UPM Pharmaceuticals (upm-inc) is listed for cdmo. Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.

Services: 12. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (12).

Review summary: Review summary withheld until site-level review gate opens.